Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
23 mai 2024 09h05 HE
|
ResMed Inc.
New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
16 mai 2024 16h35 HE
|
ResMed Inc.
ATS 2024: New ResMed-Supported Research Shows
Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
15 mars 2024 03h05 HE
|
ResMed Inc.
ResMed announced the results of its 2024 Global Sleep Survey, uncovering a world in sleep crisis and encouraging people to discover their sleep superpowers
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
06 mars 2024 09h05 HE
|
ResMed Inc.
ResMed unveils the AirFit F40, an ultra-compact full-face CPAP mask offering the comfort of smaller masks without sacrificing performance.
Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep
05 févr. 2024 04h00 HE
|
Blue California Ingredients
Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a...
Nox Health Closes Acquisition of Somryst, the Only FDA-Cleared Digital Insomnia Treatment, From Pear Therapeutics
20 juin 2023 11h56 HE
|
Nox Health
ALPHARETTA, Ga., June 20, 2023 (GLOBE NEWSWIRE) -- Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced that it has closed the...
Nox Health Acquires Somryst, the Only FDA-Cleared Digital Insomnia Treatment
25 mai 2023 09h46 HE
|
Nox Health
ALPHARETTA, Ga. , May 25, 2023 (GLOBE NEWSWIRE) -- Nox Health, a global sleep health leader, has acquired Somryst, the first FDA-cleared Prescription Digital Therapeutic (PDT) that delivers...
UPDATE--Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
05 avr. 2023 16h31 HE
|
Nox Health
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Nox Medical has secured a new patent to measure breathing movements for determining endophenotypes of sleep-disordered breathing using Nox RIP...
Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
04 avr. 2023 15h53 HE
|
Nox Health
ALPHARETTA, Ga., April 04, 2023 (GLOBE NEWSWIRE) -- The United States Patent Office recently granted Nox Medical a new patent for methods supporting accurate diagnoses of sleep apnea, which are...
Nox Health Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
23 mars 2023 11h08 HE
|
Nox Health
ALPHARETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- Nox Health, a global sleep health leader, has joined the American Heart Association Center for Health Technology & Innovations (the Center)...